by vittorio | Mar 11, 2019 |
MyoGene Bio is developing cutting edge therapeutics for muscle diseases, starting with a gene editing therapy for Duchenne muscular dystrophy. Market:Duchenne muscular dystrophy (DMD) is a severe, progressive muscle wasting disorder that affects approximately 1 in...
by vittorio | Mar 11, 2019 |
Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...
Recent Comments